Ascitic non-HDL-C/ HDL-C Ratio: A Novel Prognostic Marker in Liver Cirrhosis

Faculty Medicine Year: 2020
Type of Publication: ZU Hosted Pages: 30
Authors:
Journal: مجلة علوم الرياضة كلية التربية الرياضية- جامعة المنيا. FACULTY OF MEDICINE ZAGAZIG UNIVERSITY Volume: 2746-1687
Keywords : Ascitic non-HDL-C/ HDL-C Ratio: , Novel Prognostic    
Abstract:
Background and study aim: Laboratory tests were developed on ascitic fluid for assessing causes, mechanisms, and prognosis of the diseases. This study aimed to evaluate the prognostic value of ascitic lipids in cirrhosis with special consideration to the non-high-density lipoprotein cholesterol (non-HDL-C) and its related ratios. Methods: This cross-sectional study included 120 cirrhotic patients with ascites. Ascitic fluid analysis for lipid contents and calculations of ratios were done. Ascitic lipid contents and ratios are used to assess liver disease severity and predict the mortality in patients groups with different Child-Pugh classes. Results: Regarding Child-Pugh score, ascitic cholesterol, and HDL-C showed significantly higher levels in group Cwhen compared to groups A and B. Ascitic non-HDL-C and ascitic non-HDLC/ HDL-C ratio had a statistically significant increasing trend among ChildPugh groups. Serum-ascites cholesterol gradient showed no significant difference among Child-Pugh groups (p>0.05). Ascitic non-HDL-C/ HDL-C ratio had the highest positive linear correlation with cirrhosis severity scores (p<0.0001). High ascitic non-HDL-C/ HDL-C ratio patients had a higher mortality rate when compared to those with a lower ratio (38.5% versus 9.5%). Conclusion: Ascitic non-HDL-C/HDL-C ratio was more beneficial than non-HDLC level in cirrhosis severity prediction. Also, it could predict the cirrhotic patients' survival. So, Ascitic non-HDLC/HDL-C ratio seems to be an excellent prognostic marker for cirrhosi
   
     
 
       

Author Related Publications

  • Alsayed Saad Abdelbader Saad, "A study of the Role of 25 Hydroxy-Cholecalciferol Level on Non Alcoholic Fatty Liver Disease (NAFLD) in a Cohort of Egyptian Patients", faculity of medicine zagazig university, 2018 More
  • Alsayed Saad Abdelbader Saad, "Evaluation of HCV-associated Hepatocellular Carcinoma Based on Alpha-fetoprotein Levels", faculity of medicine zagazig university, 2020 More
  • Alsayed Saad Abdelbader Saad, "Current evaluation of sepsis among patients with liver cirrhosis", faculity of medicine zagazig university, 2018 More
  • Alsayed Saad Abdelbader Saad, "Brucellosis Relapse: A Retrospective Study of Risk Factors among Saudi Patients", faculity of medicine zagazig university, 2018 More
  • Alsayed Saad Abdelbader Saad, "IL-1α and TGF-β1 as non-Invasive Liver Fibrosis Markers of Chronic Liver Injury among Chronic Liver Diseases Patients in Sharkia Governorate, Egypt", faculity of medicine zagazig university, 2020 More

Department Related Publications

  • Ibrahim Mohammed Ibrahim Ahmed, "تحسين تشخيص تضيق القناة الصفراوية البعيدة: التصوير بالموجات فوق الصوتية بالمنظار للكشف عن الكتل غير المكتشفة في التصوير المقطعي", Afroegyptian journal of endemic diseases, 2025 More
  • Mohamed Ahmed Mohamed Suleiman Saraya, "Relationship Between Plasma Concentrations of Interleukin-10 and Thrombocytopenia In Chickenpox Patients العلاقة بين مستويات الانترلوكين 10 في مصل الدم وانخفاض الصفائح الدموية في مرضي الجديري المائي", ِِِAfro-Egyptian Journal of Infectious and Endemic Diseases, 2016 More
  • Hossam Mohamed Sayed Mouhammid, "Evaluation of some pulmonary functions and pleuropulmonary complications after endoscopic sclerotherapy of gastric fundal varices at Zagazig university hospitals", The Egyptian Society of Chest Diseases and Tuberculosis, 2016 More
  • Abeer Mohamed Abdelaziz Nafea, "Antimicrobial Resistance Trends and Distribution of Virulence Genes Among Shigella Clinical Isolates From Patients With Acute Diarrhea اتجاه مقاومة مضادات الميكروبات وتوزيع الجينات الممرضة فى المعزولات الإكلينيكية لميكروب الشغلة من المرضى ا", مجلة كلية الطب, 2010 More
  • Ahmed Saied Mohamed Ibrahem, "Biliary Stent Migration: Why, How, and What", Wolters Kluwer Health, 2021 More
Tweet